TB-500 (Thymosin Beta-4): Complete Research Peptide Guide

———–|——–|———–|———-|

Loading phase 4-5 mg Twice weekly 2-3 weeks Maintenance 2-2.5 mg Once weekly 4-6 weeks Acute injury study 5 mg Every 3-4 days 2-4 weeks Chronic condition 2 mg Once weekly 8-12 weeks

Total research cycle typically ranges from 4-12 weeks depending on the study design. Many researchers combine TB-500 with BPC-157 for synergistic tissue repair effects.

TB-500 vs. BPC-157: Understanding the Differences

While both peptides are researched for tissue repair, they have distinct characteristics:

Aspect TB-500 BPC-157 Primary action Systemic cell migration Localized tissue protection Best for Overall recovery, flexibility Specific injury sites, gut health Dosage size 2-5 mg 200-500 mcg Onset of effects Gradual (1-2 weeks) Rapid (3-7 days) Mobility focus Yes (joint flexibility) Less pronounced Gastrointestinal effects Minimal Significant

Hanpro Peptides offers a pre-blended BPC + TB combination for researchers studying synergistic protocols.

How to Reconstitute TB-500

Proper reconstitution ensures peptide stability and accurate dosing:

Sanitize the vial stopper with alcohol

Add bacteriostatic water (recommended: 2mL for 5mg vial = 2.5mg/mL)

Swirl gently until fully dissolved — never shake vigorously

Refrigerate at 2-8°C after reconstitution

Use within 30 days for optimal potency

For precise dosing calculations, use our Peptide Reconstitution Calculator.

TB-500 Purity and Quality Considerations

Research-grade TB-500 should meet these standards:

HPLC purity: ≥98% (ideally >99%)

Mass spec confirmation: Verifies correct molecular weight

Endotoxin levels: <0.1 EU/μg for cell culture work

Appearance: White, fluffy lyophilized powder

Storage: -20°C for long-term, 2-8°C short-term

Hanpro Peptides provides Certificates of Analysis with third-party testing for all TB-500 products, ensuring research-grade quality and consistency.

TB-500 Side Effects in Research

Preclinical studies have generally reported TB-500 as well-tolerated. Documented research observations include:

Injection site reactions: Mild redness or discomfort (common)

Fatigue: Temporary tiredness, especially during loading phase

Headaches: Occasional reports at higher doses

Nausea: Rare, typically at doses above 5mg

Temporary lethargy: Some animal models show reduced activity initially

No serious adverse events have been reported in published preclinical research. However, long-term safety data remains limited, and TB-500 should only be used in controlled research environments.

Where to Buy TB-500 for Research

Hanpro Peptides offers high-purity TB-500 with:

Purity: >99% HPLC verified

Available sizes: 2mg, 5mg, 10mg vials

Format: Lyophilized powder

Worldwide shipping: 7-15 day delivery with tracking

Quality guarantee: Third-party tested with CoA available

Purchase TB-500 Online from Hanpro Peptides — trusted by research facilities worldwide.

Related Research Peptides

Expand your research with these complementary peptides:

BPC-157 — Direct tissue repair and gastroprotection

GHK-Cu — Skin regeneration and anti-aging research

Thymosin Alpha-1 — Immune system modulation

Sermorelin Acetate — Growth hormone releasing studies

Frequently Asked Questions

How is TB-500 different from Thymosin Beta-4?

TB-500 is a synthetic fragment containing the active region of full-length Thymosin Beta-4. It is more stable, easier to manufacture, and has a longer shelf life while retaining the primary biological effects of the parent molecule.

How long does TB-500 stay in your system?

TB-500 has a relatively short half-life of approximately 2-4 hours in circulation. However, its biological effects persist much longer due to downstream cellular changes, which is why once-weekly dosing is common in research protocols.

Can TB-500 be taken orally?

TB-500 is a peptide and would be broken down by digestive enzymes if taken orally. Subcutaneous or intramuscular injection is the standard research administration route for reliable bioavailability.

What does TB-500 do for joints?

In preclinical research, TB-500 has shown potential to improve joint mobility by promoting synovial fluid production, reducing inflammation, and supporting cartilage and connective tissue regeneration. These effects are still under investigation.

---

*Disclaimer: This content is for educational and research informational purposes only. TB-500 is a research-use-only compound not approved for human or animal consumption. All information is based on preclinical studies and does not constitute medical advice.*